For: | Hassan SA, Kapur N, Sheikh F, Fahad A, Jamal S. Disease clearance in ulcerative colitis: A new therapeutic target for the future. World J Gastroenterol 2024; 30(13): 1801-1809 [PMID: 38659483 DOI: 10.3748/wjg.v30.i13.1801] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i13/1801.htm |
Number | Citing Articles |
1 |
Changfeng Qu, Chen Liang, Tianlong Liu, Yingying He, Ke Ke, Jinlai Miao. Natural zinc-rich oyster peptides ameliorate DSS-induced colitis via antioxidation, anti-inflammation, intestinal barrier repair, microbiota modulation, and SCFA accumulation. Food Bioscience 2024; 61: 104801 doi: 10.1016/j.fbio.2024.104801
|
2 |
Öykü Altınok, Murat Baş, Elif Gelenli Dolanbay, Meltem Kolgazi, Tugay Mert, Ünal Uslu. Collagen Peptides and Saccharomyces boulardiiCNCM I‐745 Attenuate Acetic Acid‐Induced Colitis in Rats by Modulating Inflammation and Barrier Permeability. Food Science & Nutrition 2025; 13(4) doi: 10.1002/fsn3.70189
|
3 |
Lucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, Ferdinando D’Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca. Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals 2025; 18(1): 78 doi: 10.3390/ph18010078
|
4 |
Fabrizio Fanizzi, Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese, Axel Dignass. Treatment targets in IBD: is it time for new strategies?. Best Practice & Research Clinical Gastroenterology 2025; : 101990 doi: 10.1016/j.bpg.2025.101990
|
5 |
Shao-Jie Liang, Kun Wang, Da-Bin Mao, Li-Wei Xie, Da-Jian Zhu. Inhibition of the Wnt/β‑catenin signaling pathway and SOX9 by XAV939 did not alleviate inflammation in a dextran sulfate sodium‑induced ulcerative colitis model. Experimental and Therapeutic Medicine 2024; 29(2) doi: 10.3892/etm.2024.12774
|